Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

TransMedics (TMDX) Interest Expenses (2018 - 2026)

TransMedics has reported Interest Expenses over the past 8 years, most recently at $3.4 million for Q4 2025.

  • For Q4 2025, Interest Expenses fell 6.08% year-over-year to $3.4 million; the TTM value through Dec 2025 reached $13.8 million, down 4.35%, while the annual FY2025 figure was $13.8 million, 4.35% down from the prior year.
  • Interest Expenses for Q4 2025 was $3.4 million at TransMedics, down from $3.5 million in the prior quarter.
  • Over five years, Interest Expenses peaked at $3.6 million in Q2 2024 and troughed at $787000.0 in Q3 2022.
  • A 5-year average of $2.3 million and a median of $2.9 million in 2023 define the central range for Interest Expenses.
  • Biggest five-year swings in Interest Expenses: dropped 19.61% in 2022 and later surged 356.16% in 2023.
  • Year by year, Interest Expenses stood at $978000.0 in 2021, then rose by 2.97% to $1.0 million in 2022, then soared by 257.99% to $3.6 million in 2023, then fell by 0.94% to $3.6 million in 2024, then decreased by 6.08% to $3.4 million in 2025.
  • Business Quant data shows Interest Expenses for TMDX at $3.4 million in Q4 2025, $3.5 million in Q3 2025, and $3.5 million in Q2 2025.